Centaurus Financial, Inc. Novavax Inc Transaction History

Centaurus Financial, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $71,752 - $147,044	-1,029 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$134.56 - $217.97 $62,570 - $101,356	465 Added 82.45%	1,029 $147,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $8,890 - $13,529	50 Added 9.73%	564 $117,000
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $31,581 - $67,251	-261 Reduced 33.68%	514 $109,000
Q1 2021 Apr 30, 2021	SELL	$112.98 - $319.93 $52,309 - $148,127	-463 Reduced 37.4%	775 $141,000

Q4 2020 Jan 25, 2021	SELL	$78.74 - $139.5 $76,299 - $135,175	-969 Reduced 43.91%	1,238 $138,000
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $33,523 - $75,331	422 Added 23.64%	2,207 $239,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $24,740 - $149,243	1,785 New	1,785 $149,000

242

76.1M

5.06M

7.19M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.01B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.